Laboratory-related issues in the measurement of cardiac troponins with highly sensitive assays.

Clinical Chemistry and Laboratory Medicine : CCLM
Magdalena Krintus, Mauro Panteghini

Abstract

A number of assay-related issues can affect the performance of cardiac troponin (cTn) measurement in everyday practice. In this respect, it is vital that all information on cTn assays is known and that the performance characteristics of assays are objectively assessed and adequately described. The advent of the latest generation of more sensitive cTn assays has heralded a new wave of information about low concentrations of cTn in blood. These recent generation assays have improved analytical sensitivity and corresponding performance at low cTn concentrations when compared to their predecessors, providing a convincing goal for laboratory medicine in helping clinicians in the diagnosis of acute myocardial infarction. Crucial to the clinical utility of highly sensitive cTn assays is the laboratorians' role in closely scrutinizing proposed assays and defining their value in relation to available evidence. Analytical, as well as pre-analytical and post-analytical, aspects must be documented. In this review, we describe what laboratory professionals should know about their cTn assay performance characteristics and the pre-analytical prerequisites for robustness to ensure optimal post-analytical reporting.

References

Jan 1, 1997·Annals of Clinical Biochemistry·C G FraserC Ricos
Jun 1, 2002·Annals of Clinical Biochemistry·Paul SheehanSamuel D Vasikaran
Aug 11, 2004·Clinical Biochemistry·Martha E LyonAndrew W Lyon
Jan 5, 2006·Annals of Clinical Biochemistry·Ravinder SodiAlan Shenkin
May 1, 2007·Annals of Emergency Medicine·David A GussJames P Killeen
Oct 24, 2007·European Heart Journal·Kristian ThygesenUNKNOWN Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction
May 17, 2008·Annals of Clinical Biochemistry·Jillian R TateAndrew Carter
Jan 27, 2009·Clinica Chimica Acta; International Journal of Clinical Chemistry·Mauro Panteghini
Aug 28, 2009·The New England Journal of Medicine·David A Morrow
Sep 26, 2009·Clinical Chemistry and Laboratory Medicine : CCLM·Ana-Maria SimundicElizabeta Topic
Nov 17, 2010·Clinical Chemistry and Laboratory Medicine : CCLM·Aihong Li, Göran Brattsand
Jan 12, 2011·Clinica Chimica Acta; International Journal of Clinical Chemistry·A K SaengerA S Jaffe
Mar 11, 2011·Clinical Chemistry and Laboratory Medicine : CCLM·Etienne C H J MichielsenMarcel J W Janssen
Aug 31, 2011·Critical Reviews in Clinical Laboratory Sciences·Giuseppe LippiGianfranco Cervellin
May 29, 2012·The American Journal of Emergency Medicine·Roland BingisserPer Venge
Jun 23, 2012·European Heart Journal·Kristian ThygesenUNKNOWN Study Group on Biomarkers in Cardiology of ESC Working Group on Acute Cardiac Care
Jan 1, 2011·Clinical Chemistry and Laboratory Medicine : CCLM·Mauro Panteghini
Aug 28, 2012·European Heart Journal·Kristian ThygesenUNKNOWN ESC Committee for Practice Guidelines (CPG)
Sep 5, 2013·International Journal of Cardiology·Madeleine H E Bruins SlotFrans H Rutten
Sep 18, 2013·Journal of Clinical Pathology·Michael SinnottGoce Dimeski
Nov 12, 2013·Clinica Chimica Acta; International Journal of Clinical Chemistry·J H BarthUNKNOWN IFCC Working Group on Standardization of Cardiac Troponin I
Feb 12, 2014·Clinica Chimica Acta; International Journal of Clinical Chemistry·Alberto Dolci, Mauro Panteghini
Mar 5, 2014·Scandinavian Journal of Clinical and Laboratory Investigation·Giuseppe Lippi
Jun 5, 2014·Clinical Chemistry and Laboratory Medicine : CCLM·Magdalena KrintusGrazyna Sypniewska
Oct 3, 2014·Clinical Chemistry and Laboratory Medicine : CCLM·Simona Ferraro, Mauro Panteghini
Oct 18, 2014·Clinical Chemistry and Laboratory Medicine : CCLM·Beret E Amundson, Fred S Apple
Jan 9, 2015·Annals of Clinical Biochemistry·Gareth C McKeeman, Peter W Auld
Dec 1, 2012·Global Heart·Kristian ThygesenHarvey D White
Apr 15, 2015·Clinical Chemistry and Laboratory Medicine : CCLM·Federica BragaMauro Panteghini
Apr 20, 2016·Clinical Chemistry and Laboratory Medicine : CCLM·Janet V Warner, George A Marshall
May 15, 2016·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Richard BodyUNKNOWN TRAPID-AMI Investigators
Jun 24, 2016·Clinical Chemistry·Jacobus Petrus Johannes UngererCarel Jacobus Pretorius
Jul 28, 2016·Clinical Chemistry·Paul CollinsonUNKNOWN Working Group for Cardiac Markers, European Federation of Clinical Chemistry and Laboratory Medicine
Aug 11, 2016·Clinical Chemistry and Laboratory Medicine : CCLM·Ferruccio CeriottiMauro Panteghini
Oct 13, 2016·Clinical Chemistry and Laboratory Medicine : CCLM·Marie-Liesse PikettyJean-Claude Souberbielle

❮ Previous
Next ❯

Citations

Jul 9, 2020·Clinical Chemistry and Laboratory Medicine : CCLM·Federica BragaMauro Panteghini
Oct 21, 2020·Clinical Chemistry and Laboratory Medicine : CCLM·Peter A KavsakAndrew Worster
Jul 25, 2021·Journal of Clinical Medicine·Abass EidizadehLutz Binder
Jul 6, 2021·Clinical Chemistry and Laboratory Medicine : CCLM·Elena Revuelta-LópezAntoni Bayes-Genis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.